Results 221 to 230 of about 213,325 (345)

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

open access: yesEpilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang   +3 more
wiley   +1 more source

Effects of Day‐Patient Treatment on Eating Disorder Symptoms in Persons With Bulimia Nervosa: A Meta‐Analysis

open access: yesEuropean Eating Disorders Review, EarlyView.
ABSTRACT Objective Outpatient treatment for bulimia nervosa (BN) often fails to reduce core symptoms like binge eating and purging, while inpatient care is costly and separates patients from their everyday environment. Day‐patient treatment offers a middle ground by providing intensive daytime therapy with the opportunity to apply skills at home.
Anna L. Dieffenbacher   +2 more
wiley   +1 more source

Early Response to an Integrated Family and Adolescent‐Focussed Treatment for Anorexia Nervosa and Atypical Anorexia Nervosa

open access: yesEuropean Eating Disorders Review, EarlyView.
ABSTRACT Objective Recovery rates for adolescent anorexia nervosa (AN) remain poor, requiring creativity within the field to explore alternative treatment options. One novel, evidence‐informed approach integrates both family/parent and individual adolescent‐focussed treatment components, through an individualised developmental lens. This study aimed to
Marion E. Roberts, Sarah L. Brandeis
wiley   +1 more source

When Rare Is Not Small: Amyotrophic Lateral Sclerosis Initiatives and Therapy

open access: yesExploration, EarlyView.
In the precision‐medicine era, rare diseases must not be sidelined in translational infrastructure. The Mr. Cai Lei—led “Ice‐Breaking Team” turns an amyotrophic lateral sclerosis patient community into a sustainable ecosystem, realigning philanthropy, data, and research and development to reshape rare‐disease pipelines and guide precision therapies ...
Yang Liu   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy